Rachael Davies
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Effect of fiber, antispasmodics and peppermint oil in irritable bowel syndrome: Systematic review and meta-analysis
Fibre,
antispasmodics and peppermint oil are all effective therapies for
irritable bowel syndrome (IBS) and should become first-line treatments,
according to a study on bmj.com today.
National guidelines on the management of IBS should be updated in light of this evidence, say the authors.
IBS
is characterised by abdominal pain and an irregular bowel habit, and
affects between 5% and 20% of the population. Because the exact cause
of IBS is unknown it is difficult to treat. A wide range of therapies
are currently used including fibre supplements, probiotics,
antidepressants, hypnotherapy and laxatives.
Because of a lack
of suitable drug treatments, international and national guidelines
promote the use of complementary and alternative treatments, including
the recently published National Institute of Health and Clinical
Excellence (NICE) guidelines on the management of IBS.
Fibre,
antispasmodics and peppermint oil are used to treat IBS, but evidence
of their effectiveness is unclear because of conflicting conclusions
and errors in previous studies.
In an attempt to resolve this
uncertainty, Dr Alex Ford and colleagues performed a systematic review
and meta-analysis of randomised trials comparing fibre, antispasmodics
and peppermint oil with placebo or no treatment in more than 2500 adult
patients with IBS..
Fibre, antispasmodics and peppermint oil
were all found to be effective treatments for IBS. The number needed to
treat to prevent IBS symptoms in one patient was 11 for fibre, 5 for
antispasmodics, and 2.5 for peppermint oil. None of the treatments had
serious adverse effects.
The researchers analysed 12 studies
which compared fibre with placebo or no treatment involving 591
patients. Interestingly, insoluble fibre such as bran was not
beneficial, only isphaghula husk (soluble fibre) significantly reduced
symptoms.
They identified 22 studies comparing various
antispasmodics with placebo in 1778 patients. Hyoscine was the most
successful at preventing symptoms of IBS. The authors suggest that
hyoscine, which is extracted from the cork wood tree, be used as the
first-line antispasmodic therapy in primary care.
Peppermint oil seemed to be the most effective treatment of the three, based on four trials involving 392 patients.
These
treatments have been overlooked because of the introduction of newer
more expensive drugs which were withdrawn due to lack of efficacy and
safety concerns, say the authors. All three treatments have been shown
to be potentially effective therapies for IBS and current national and
international guidelines need to be revised to include this new
evidence, they add.
The results of this study should "reawaken
interest in the pharmacotherapy of irritable bowel syndrome and
stimulate further research", says Professor Roger Jones from King's
College London.
However, he cautions that this new evidence
must not detract from the need to make a holistic diagnosis and
integrated approach to the treatment of IBS which takes account of the
physical, psychological, and social factors involved.
Source: BMJ-British Medical Journal
|